The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 32-37

  Ahmed, Abu Baker E ^a   Home, Philip D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; HUMAN INSULIN; INSULIN LISPRO; NEUTRAL INSULIN;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; MALE; NIGHT;

EID: 0031964961     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.32     Document Type: Article

References (42)

1. Frier BM: Hypoglycaemia in diabetes mellitus. In Textbook of Diabetes. 2nd ed. Pickup JC, Williams G, Eds. Oxford, U.K., Blackwell Science, 1997, p. 40.1-40.23
2. Bolli GB, Pirriello G, Fanelli CG, De Feo P: Nocturnal blood glucose control in type I diabetes mellitus. Diabetes Care 16 (Suppl. 3):71-85, 1993
3. Pramming S, Thorsteinsson B, Bendtson I, Ronn B, Binder C: Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin. Br Med J 291:376-379, 1985
4. Home PD: Insulin therapy. In International Textbook of Diabetes Mellitus. 2nd ed.. Alberti KGMM, De Fronzo RA, Zimmet P, Eds. Chichester, U.K., Wiley, 1997, p. 899-928
5. Roy B, Chou MCY, Field JB: Time-action characteristics of regular and NPH insulin in insulin-treated diabetics. J Clin Endocrinol Metab 50:475-480, 1986
6. Owens DR: Human Insulin: Clinical Pharmacology Studies in Normal Man. Lancaster, PA, MTP Press, 1986, p. 46-70
7. Home PD, Pickup JC, Keen H, Alberti KGMM, Parson JA, Binder C: Continuous subcutaneous insulin infusion: comparison of plasma insulin profile after infusion or bolus injection of mealtime dose. Metabolism 30:439-442, 1981
8. Gardner DF, Arakaki RF, Podet EJ, Nell LJ, Thomas JW, Field JB: The pharmacokinetics of subcutaneous regular insulin in type 1 diabetic patients: assessment using glucose clamp technique. J Clin Endocrinol Metab 63:689-694, 1986
9. Heinemann L, Richter B: Clinical pharmacology of human insulin. Diabetes Care 16 (Suppl. 3):90-99, 1993
10. Heine RJ, Bilo HJG, Fonk T, van der Veen EA, van der Meer J: Absorption kinetics and action profile of mixtures of short- and intermediate-acting insulin. Diabetologia 27:558-562, 1984
11. Barnett AH, Owen DR: Insulin analogues. Lancet 349:47-51, 1997
12. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
13. Heinemann L, Starke AAR, Heding L, Jensen I, Berger M: Action profiles of fast onset insulin analogues. Diabetologia 33:384-386 1990
14. Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, Di Vincenzo A, Epifano L, Ciofetta M, Pampabelli S, Brunetti P, Bolli GN: Pharmacokinetics, pharmacodynamics, and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28), Pro(B29)] in IDDM. Diabetologia 37:713-720, 1994
15. Betz JL: Fast-acting human insulin analog: a promising innovation in diabetic care. Diabetes Educ 21:195-200, 1995
16. Howey DC, Hooper SA, Bowsher RR: [Lys(B28), Pro(B29)]-human insulin: an equipotent analog of human insulin with rapid onset and short duration of action (Abstract). Diabetes 40 (Suppl. 1):423A, 1990
17. Ter Braak EW, Bianchi R, Erkelens DW: Faster, shorter, and more profound action of Lys(B28)Pro(B29) human insulin analogue compared to regular insulin irrespective of the injection site (Abstract). Diabetes 42 (Suppl. 1):207A, 1993
18. Hanning I, Home PD, Alberti KGMM: Measurement of free insulin concentration: the influence of the timing of extraction of insulin antibodies. Diabetologia 28:831-835, 1988
19. Soeldner JS, Slone D: Critical variables in the RIA of serum insulin using the double antibody technique. Diabetes 14:771-779, 1965
20. Harrison J, Hodson AW, Skillen AW Stappenbeck R, Agius L, Alberti KGMM: Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate, and acetoacetate measurements in man using a centrifugal analyser with fluorimetric attachment. J Chem Clin Biochem 26:141-146, 1988
21. Kustner E, Frost T, Pfutzner A, Trautmann M, Beyer J: Insulin lispro improves blood glucose control without increase in the frequency of hypoglycaemia (Abstract). Diabetologia 38 (Suppl. 1):A190, 1995
22. Anderson JH, Brunelle RL, Vignati L: Insulin lispro improves postprandial glucose control and reduced hypoglycaemia rate in type 1 diabetes (Abstract). Diabetologia 38 (Suppl. 1):A3, 1995
23. Garg S, Carmain JA, Braddy KC, Jennings MK, Chase HP: Premeal insulin analog (Lys-Pro) vs. human regular insulin treatment in young type 1 diabetes (Abstract). Diabetes 43 (Suppl. 1):162A, 1994
24. Vignati L, Brunelle RL: Treatment of 722 patients with type II diabetes with insulin lispro in a 6-month crossover study (Abstract). Diabetes 44 (Suppl. 1):229A, 1995
25. Nielsen FS, Jorgensen LN, Ipsen M, Voldsgaard AI, Parving HH: Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. Diabetologia 38:592-598, 1995
26. Torlone E, Modarelli F, Pampanelli S, Epifano L, Lalli C, Kassi G, Del Sindaco P, Perriello G, Di Vincenzo A, Brunetti P, Rambotti AM, Bolli G: Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care 19:945-952, 1996
27. Torlone E, Pampanelli S, Lalli C, Di Vincenzi A, Epifano L, Rambotti AM, Kasso G, Brunetti P, Bolli GB: Postprandial glycemic control in IDDM after s.c. LysPro insulin analogue or human regular insulin, alone or mixed with NPH (Abstract). Diabetes 44 (Suppl. 1):71A, 1995
28. Jorgensen LN, Ipsen M, Voldsgaard AI, Nielsen FS: Comparison of human insulin analogue B10Asp and regular insulin in insulin-dependent diabetic patients on basal/bolus insulin regimen (Abstract). Diabetes 40 (Suppl. 1):464A,1990
29. Trautmann ME: Effect of the insulin analogue [Lys(B28), Pro(B29)] on blood glucose control. Horm Metab Research 26:588-590, 1994
30. Heinemann L, Heise T, Wahl LCh, Trautmann ME, Starke AAR: Prandial glycaemia after a carbohydrate-rich meal in type 1 diabetic patients: using the rapid acting insulin analogue [Lys(B28),Pro(B29)] human insulin. Diabet Med 13:625-629, 1996
31. Pampanelli S, Torlone E, Lalli C, Del Sindaco P, Cioffetta M, Lepore M, Bartocci L, Brunetti P, Bolli G: Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic B-cell function. Diabetes Care 18: 1452-1460, 1995
32. Anderson JH Jr, Brunelle RL, Koivisto VA, Pfutzner A, Trautmann ME: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 46:265-270, 1997
33. Dimitriadis G, Gerich J: Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374-377, 1985
34. Lean MEJ, Ng LL, Tennison BR: Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J 290:105-108, 1985
35. Jorgensen LN, Nielsen FS: Timing of premeal insulins in diabetic patients on a multiple daily injection regimen: a questionnaire study (Abstract). Diabetologia 33:A116, 1990
36. Pieber TR, Feinbock C, Rabensteiner D, Weitgasser R, Ristic S: Lispro insulin analog in twice-a-day insulin treatment (Abstract). Diabetologia. 38 (Suppl. 1):A3, 1995
37. Vignati L, Anderson JH, Szwast S, Symanowski S: Twice daily lispro results in less glucose variability compared to human regular insulin (Abstract). Diabetologia 38:A190, 1995
38. Brunelle RL, Symanowski S, Anderson JH Jr, Vignati L: Less nocturnal hypoglycemia with insulin lispro in comparison to human regular (Abstract). Diabetes 44 (Suppl. 1):111A, 1995
39. Short R: Nighttime hypoglycaemia. Lancet 359:1628-1629, 1995
40. Holcombe J, Zalani S, Arora V, Headlee S, Gill A: Insulin lispro (LP) results in less nocturnal hypoglycemia compared with regular insulin in adolescents with type 1 diabetes (Abstract). Diabetes 46 (Suppl. 1):103A, 1997
41. Jansson PA, Ebeling P, Smith U, Conget I, Coves M, Gomis R, Lalli C, Bolli G, Koivisto V: Glycemic control in IDDM is improved by optimized combination of insulin lispro and basal insulin (Abstract). Diabetes 46 (Suppl. 1):162A, 1997
42. Del Sindaco P, Ciofetta M, Lalli C, Torlone E, Perriello G, Brunetti P, Bolli G: Importance of basal insulin to improve control without increasing hypoglycaemia in intensively treated IDDM using a short-acting insulin analog at meals (Abstract). Diabetologia 40 (Suppl. 1):352A, 1997